Sébastien Tabariès

8PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 01, 2026
Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC.

|Apr 15, 2026
PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.

|Jun 21, 2024
Anti-Claudin-2 Antibody-Drug Conjugates for the Treatment of Colorectal Cancer Liver Metastasis.

Sébastien Tabariès, Alma Robert, Anne Marcil

|Aug 12, 2022
CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells.

Shufeng Zhou, Amani Hassan, Tenzin Kungyal

|Jun 01, 2022
Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

Emily Latacz, Diederik Höppener, Ali Bohlok

|Aug 11, 2021
Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases.

Miran Rada, Audrey Kapelanski-Lamoureux, Stephanie Petrillo

Pageof 2

Frequent Collaborators

6 joint publications

Peter Siegel

3 joint publications

Anthoula Lazaris

2 joint publications

Matthew G Annis

2 joint publications

Dirk J Grünhagen